Cargando…
Itgb3-integrin-deficient mice may not be a sufficient model for patients with Glanzmann thrombasthenia
Itgb3-integrin-deficient (Itgb3(−/−)) mice have been reported as a Glanzmann thrombasthenia (GT) model and have been used for platelet research. However, it remains unclear whether this mouse model can fully simulate patients with GT or whether it has different characteristics from these patients. T...
Autores principales: | Li, Dongya, Peng, Jie, Li, Tiantian, Liu, Yichen, Chen, Min, Shi, Xiaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060805/ https://www.ncbi.nlm.nih.gov/pubmed/33880575 http://dx.doi.org/10.3892/mmr.2021.12088 |
Ejemplares similares
-
Glanzmann thrombasthenia
por: Nurden, Alan T
Publicado: (2006) -
Novel homozygous silent mutation of ITGB3 gene caused Glanzmann thrombasthenia
por: Wang, Zhengrong, et al.
Publicado: (2023) -
Glanzmann’s thrombasthenia and molecular mimicry
por: Wiwanitkit, Viroj
Publicado: (2010) -
Disease Burden in Patients with Glanzmann’s Thrombasthenia: Perspectives from the Glanzmann’s Thrombasthenia Patient/Caregiver Questionnaire
por: Duncan, Alexander, et al.
Publicado: (2020) -
The Glanzmann Thrombasthenia Registry: safety of platelet therapy in patients with Glanzmann thrombasthenia and changes in alloimmunization status
por: Poon, Man-Chiu, et al.
Publicado: (2023)